Navigation Links
DaVita Treats Thousands of Dialysis Patients in Wake of Hurricane Ike

57 of DaVita's 58 Houston Dialysis Centers Open

EL SEGUNDO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, is caring for thousands of dialysis patients, despite the loss of power to millions of people in the Houston area. DaVita's Emergency Response Team had hundreds of teammates supplying the necessary materials and generators to deliver vital dialysis treatment during and after the storm. Nearly all DaVita's fifty-eight centers are up and running, some solely on generator power. Kidney failure patients depend on dialysis treatments three times per week which requires water, electricity and specially trained medical staff to maintain their health.


Larry Crist, DaVita(R) Divisional Vice President for Texas says, "Although we faced significant challenges during the storm, our teammates (employees) have come together to prove that DaVita will stop at nothing to make sure our patients receive the best care possible." DaVita teammates have been working around the clock to make sure patients receive life-sustaining dialysis care. Crist says, "Our teammates, lived the mission of Provider of Choice by returning to clinics to assist patients, despite the fact that several teammate's homes were destroyed."

Aside from the constant support of our teammates in and around the Houston area, our Guest Service Contact Center has fielded over 7,000 patient, family member and teammate calls to keep them informed regarding where patients can receive the care they need. Any patient who needs dialysis can call the Guest Service Contact Center at (800) 400-8331, which is activated 24 hours a day, 7 days a week. In addition to the Guest Service Contact Center, DaVita teammates from around the nation are raising donations and supplies for teammates whose homes were destroyed by the hurricane.

DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment.

For more information about DaVita, its kidney education and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DaVita to Present at UBS Best of Americas Conference
2. NxStage Medical Announces Needle Supply Agreement with DaVita
3. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
4. DaVita Honored for 4th Year as Training Top 125 Recipient
5. DaVita Introduces Treatment Evaluator
6. Third Annual DaVita Kidney Disease Awareness Walks to Hit 20 Cities in 2008
7. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
8. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
9. New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barretts Esophagus
10. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
11. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015  Cepheid (Nasdaq: ... ending September 30, 2015. --> ... total revenue for the third quarter of 2015 is ... per share is expected to be approximately $(0.32) for ... non-GAAP net loss per share for the third quarter ...
(Date:10/13/2015)... CAMBRIDGE, Mass. , Oct. 13, 2015 ... quantitative methodologies at critical decision points throughout the drug ... at QSP Congress Boston 2015 on October 20-22, 2015 ... John Burke , PhD, Co-Founder, President, and CEO of ... drug discovery from early research to clinical trials" on ...
(Date:10/13/2015)... , October 13, 2015 ... and development company, has entered into a strategic relationship ... and Paris, France ... --> --> This collaborative arrangement gives ... respected scientific advisory team as well as long established ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr ... company’s fast growing clinical data solutions business. , Jeff Parr has spent the past ... sizes, including Avery Dennison, Thermo Fisher, and Ab Sciex to name a few. ...
Breaking Biology Technology:
(Date:10/12/2015)... Research and Markets ( ) ... Recognition Market by Component (Hardware & Software), Product ... Industry (Travel & Immigration, Military & Defense, & ... report to their offering. ... Market worth 3627.90 Million USD by 2020 ...
(Date:10/8/2015)... LAKE CITY , 8. Oktober 2015 ... TRCK), ein global tätiges Unternehmen des Bereiches ... einem Vertrag mit der Gefängnisbehörde Virginias (Department ... dessen Rahmen elektronische Überwachungsdienste für alle Strafen ... Derek Cassell , Präsident für den ...
(Date:10/7/2015)... NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... long- term executive at American Express has been appointed ... ) ("NXT-ID" or the "Company"), a biometric authentication company ... of the Wocket® smart wallet announces Mr. Stanley ...
Breaking Biology News(10 mins):